Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2015 Jan 22:6:243-53.
doi: 10.3762/bjnano.6.23. eCollection 2015.

Release behaviour and toxicity evaluation of levodopa from carboxylated single-walled carbon nanotubes

Affiliations

Release behaviour and toxicity evaluation of levodopa from carboxylated single-walled carbon nanotubes

Julia M Tan et al. Beilstein J Nanotechnol. .

Abstract

This work explores the potential use of commercially obtained, carboxylated, single-walled carbon nanotubes (SWCNT-COOH) as nanocarriers for the antiparkinson drug, levodopa (LD). The resulting nanohybrid was characterized using materials characterization methods including Fourier transform infrared spectroscopy, Raman spectroscopy, elemental analysis, UV-vis spectroscopy and scanning electron microscopy. The results showed that SWCNT-COOH were able to form supramolecular complexes with LD via a π-π stacking interaction and exhibited favourable, slow, sustained-release characteristics as a drug carrier with a release period over more than 20 h. The results obtained from the drug release studies of LD at different pH values showed that the LD-loaded nanohybrid is pH activated. The release kinetics of LD from SWCNT-COOH were well-described by a pseudo-second-order kinetic model. A cytotoxicity assay of the synthesized nanohybrid was also carried out in PC12 cell lines (a widely used, in vitro Parkinson's model for neurotoxicity studies) using 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) assay in order to investigate their possible effects on normal neuronal cells in vitro. It was found that the synthesized nanohybrid did not compromise the cell viability and the PC12 cells remained stable throughout the experiments up to 72 h after treatment.

Keywords: MTT assay; PC12 cells; Parkinson’s disease; carboxylic acid-functionalized single-walled carbon nanotubes; levodopa; nanomedicine; sustained release.

PubMed Disclaimer

Figures

Figure 1
Figure 1
FTIR spectra of (A) SWCNT–COOH, (B) LD and (C) SWCNT–LD nanohybrid.
Figure 2
Figure 2
Raman spectra of the SWCNT–COOH nanocarrier and the SWCNT–LD nanohybrid.
Figure 3
Figure 3
Field emission scanning electron microscopy (FESEM) images of (A) SWCNT–COOH and (B) SWCNT–LD nanohybrid.
Figure 4
Figure 4
Transmission electron microscopy (TEM) micrographs of (A) SWCNT–COOH and (B) SWCNT–LD.
Figure 5
Figure 5
Release profiles of LD from SWCNT–COOH into phosphate-buffered saline solutions at pH 7.4 and pH 4.8.
Figure 6
Figure 6
Fitting data for the release of LD from SWCNT–COOH to the pseudo-first-order, pseudo-second-order and the parabolic equation for pH 7.4 (A–C) and pH 4.8 (D–F).
Figure 7
Figure 7
MTT assay of PC12 cell lines after 24, 48 and 72 h of treatment with LD, SWCNT–COOH and SWCNT–LD nanohybrid, at different concentrations. The optical density (OD) is directly correlated to the number of living cells. The data are shown as means ± standard deviation from three individual experiments.
Figure 8
Figure 8
UV–vis absorption spectra of pure LD, supernatant residue and SWCNT–COOH.
Scheme 1
Scheme 1
Suggested π–π interaction between LD molecules and carbon nanotubes in a (a) sandwich or (b) parallel-displaced interaction.

Similar articles

Cited by

References

    1. Bangham A D, Horne R W. J Mol Biol. 1964;8:660–668. doi: 10.1016/S0022-2836(64)80115-7. - DOI - PubMed
    1. Zhang R, Olin H. Mater Sci Eng, C. 2012;32:1247–1252. doi: 10.1016/j.msec.2012.03.016. - DOI
    1. Barahuie F, Hussein M Z, Gani S A, Fakurazi S, Zainal Z. Int J Nanomed. 2014;9:3137–3149. doi: 10.2147/IJN.S59541. - DOI - PMC - PubMed
    1. Frandsen J L, Ghandehari H. Chem Soc Rev. 2012;41:2696–2706. doi: 10.1039/c2cs15303c. - DOI - PubMed
    1. Elsabahy M, Nazarali A, Foldvari M. Curr Drug Delivery. 2011;8:235–244. doi: 10.2174/156720111795256174. - DOI - PubMed

LinkOut - more resources